Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xeris Biopharma Holdings (XERS) Consolidated Net Income (2020 - 2026)

Xeris Biopharma Holdings filings provide 6 years of Consolidated Net Income readings, the most recent being $11.1 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income rose 316.72% to $11.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $554000.0, a 101.01% increase, with the full-year FY2025 number at $554000.0, up 101.01% from a year prior.
  • Consolidated Net Income hit $11.1 million in Q4 2025 for Xeris Biopharma Holdings, up from $621000.0 in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $11.1 million in Q4 2025 to a low of -$50.8 million in Q4 2021.
  • Median Consolidated Net Income over the past 5 years was -$16.3 million (2023), compared with a mean of -$16.7 million.
  • Biggest five-year swings in Consolidated Net Income: crashed 132.37% in 2021 and later skyrocketed 316.72% in 2025.
  • Xeris Biopharma Holdings' Consolidated Net Income stood at -$50.8 million in 2021, then soared by 74.54% to -$12.9 million in 2022, then dropped by 3.56% to -$13.4 million in 2023, then surged by 61.81% to -$5.1 million in 2024, then skyrocketed by 316.72% to $11.1 million in 2025.
  • The last three reported values for Consolidated Net Income were $11.1 million (Q4 2025), $621000.0 (Q3 2025), and -$1.9 million (Q2 2025) per Business Quant data.